MOTS-c

MOTS-c is a sixteen amino acid peptide encoded not by the nucleus but by mitochondrial DNA, which makes it genuinely unusual. Mitochondria were once free-living bacteria, and they kept a small genome of their own; MOTS-c is one of the few peptides that genome produces.

The biology is real and interesting, and worth understanding on its own terms.

Why people are talking about it#

Where it comes from. Almost every peptide is a product of the cell nucleus. This one is written in the separate genome your mitochondria carry from their bacterial past, which means the powerhouse of the cell has its own signalling vocabulary. That discovery is a genuine one.

The second reason is the exercise link. Blood levels of MOTS-c rise when people exercise, which is one of the better-replicated observations about it, and which is what makes the exercise-mimetic framing sound plausible.

What people take it for#

Metabolic health, fat loss and energy, usually framed as getting some of the effect of exercise without doing it.

An exercise mimetic#

The claim is the metabolic benefits of training without the training. The mechanism is activation of the AMPK pathway, the cellular energy sensor that exercise itself engages, along with effects on insulin sensitivity and glucose handling.

In practice that describes telling the cell it has just been working hard. That has been demonstrated in mice, where MOTS-c improved insulin sensitivity and reduced diet-induced obesity.

Healthy ageing#

The claim is a slower metabolic decline with age. The observation behind it is that natural MOTS-c levels fall as people get older, and are lower in people with metabolic disease.

That is a correlation in observational data, and which direction it runs is exactly what a trial would establish.

What the evidence shows#

The human evidence is observational and it measures the body's own production. Studies report that plasma MOTS-c rises with exercise, that levels differ between metabolically healthy and unhealthy people, and that they decline with age.

There is no completed trial of administering MOTS-c to people, so dose, duration and effect in humans are open questions. The animal work is more substantial and comes mostly from a small number of groups, which is the pattern described in how to read a peptide study.

Reported effects from use are injection site reactions and occasional flushing.

How it is taken#

Sold as a powder for reconstitution and subcutaneous injection. No dose has been established in people, so the figures in circulation come from animal work converted by rules of thumb.

How it compares#

Against exercise itself#

Exercise raises MOTS-c along with a great many other things, and has evidence behind it that nothing in this category approaches. The mimetic framing is a claim about substitution that has not been tested.

Against NAD+ and SS-31#

NAD+ is a coenzyme and SS-31 is a different peptide with an approved relative. All three are marketed for mitochondrial function and they are unrelated molecules with separate evidence bases.

Common questions#

Does exercise raise it naturally?

Yes, and that is one of the better-replicated observations about it. It is also the finding most often used to sell the injectable version.

Has anyone taken it in a trial?

No completed human administration trial has been published.

Is it the same as NAD+ or SS-31?

No. They are unrelated molecules that happen to share a marketing category.

Why is a mitochondrial gene interesting?

Because mitochondria descend from free-living bacteria and kept their own small genome. A peptide written there is signalling from a different source than the rest of the cell's.